Angela Hubanks, PA
Medical · Dubuque, IANPI 1356538300
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.5% of the total across 129 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 26 manufacturers reported payments, led by AbbVie at 25.3% of the total. 2025 is the largest year on record at $1,116, more than ten times the $31 reported in 2021.
Across 129 payments — averaging $16.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$548
- Novo Nordisk$306
- AstraZeneca$271
- Pfizer$212
- Lilly USA, LLC$121
- Astellas Pharma US Inc$102
- plus $604 from 20 others
What the payments were for
- Food & beverage$2,13299%
- Education$321%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 34 | $548 |
| Novo Nordisk | 15 | $306 |
| AstraZeneca | 10 | $271 |
| Pfizer | 24 | $212 |
| Lilly USA, LLC | 8 | $121 |
| Astellas Pharma US Inc | 5 | $102 |
| Exact Sciences | 5 | $92 |
| Axsome Therapeutics, Inc. | 1 | $77 |
| Lundbeck LLC | 3 | $53 |
| Amgen | 3 | $43 |
| Xeris Pharmaceuticals, Inc. | 2 | $41 |
| Novartis | 2 | $36 |
| Dexcom, Inc. | 2 | $33 |
| Bayer | 2 | $30 |
| Daiichi Sankyo Inc. | 1 | $22 |
| GSK | 1 | $20 |
| Radius Health, Inc. | 1 | $19 |
| BD | 1 | $19 |
| Dynavax Technologies Corporation | 1 | $18 |
| Abbott | 1 | $16 |
| Pharmaessentia USA Corporation | 1 | $15 |
| Celltrion USA Inc. | 1 | $15 |
| Boehringer Ingelheim | 1 | $15 |
| Phathom Pharmaceuticals, Inc. | 2 | $13 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $13 |
| Medtronic | 1 | $13 |
How this compares
$2,164 in reported general payments places this provider in the 80th percentile of 141 medical providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 44 | $39,981 |
| MounjaroTirzepatide | 28 | $39,524 |
| FarxigaDapagliflozin Propanediol | 38 | $37,781 |
| XareltoRivaroxaban | 15 | $25,155 |
| EliquisApixaban | 20 | $15,099 |
| EntrestoSacubitril/Valsartan | 13 | $8,941 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 18 | $6,208 |
| Breo ElliptaFluticasone/Vilanterol | 13 | $5,517 |
| Ondansetron Hcl | 22 | $5,298 |
| LantusInsulin Glargine,hum.Rec.Anlog | 15 | $3,519 |
| Acetazolamide | 12 | $3,077 |
| Atorvastatin Calcium | 295 | $3,014 |
| Levothyroxine Sodium | 180 | $1,856 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 58 | $1,790 |
| Gabapentin | 81 | $1,717 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $306 | $39,98144 claims |
| Lilly USA, LLCMounjaro | $121 | $39,52428 claims |
| AstraZenecaFarxiga | $271 | $37,78138 claims |
| PfizerEliquis | $212 | $15,09920 claims |
| NovartisEntresto | $36 | $8,94113 claims |
| GSKBreo Ellipta | $20 | $5,51713 claims |
| AbbVieSynthroid | $548 | $58217 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 141 medical providers in Iowa.
Other medical in Dubuque
- Megan EiselDubuque$2K
- Cortney KueterDubuque$2K
- Molly BogeDubuque$2K
- Melissa CaseyDubuque$1K
- Marissa HulmeDubuque$1K
- Patricia ArasonWest Des Moines$119K
- Maria SonnackIowa City$100K
- Kristin BabbAtlantic$16K
- Laura QuinnetteCouncil Bluffs$14K
- Laurie HughellUrbandale$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.